No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Specialties
Humasis Co. Ltd. manufactures and sells pharmaceuticals and medical devices in South Korea and internationally. It offers immunodiagnostic kits, such as quantitative and qualitative tests, cardiac and cancer markers, infectious diseases, hormones, and women's health. The company also provides bio-material products, such as COVID-19 nucleocapsid protein, human immunodeficiency virus surface proteins, COVID-19 RT-PCR kit, and COVID-19 Variant RT-qPCR kit, as well as MPXV real time PCR kit, a real-time polymerase chain reaction assay for the qualitative detection of nucleic acid from Monkeypox virus. In addition, it offers diagnostic equipment, such as urinalysis, blood glucose meters, and immunodiagnostics tools. Further, it provides other test kits, such as Cotinine to test cotinine in urine; and G6PD, an in vitro diagnostic test that can detect glucose-6-phosphate dehydrogenase in human whole blood. The company was founded in 2000 and is headquartered in Anyang-si, South Korea.
www.humasis.comNo one on the platform currently holds 205470.KQ.
No tracked institution reports a position in 205470.KQ as of their last filing.
No one on the platform has traded 205470.KQ yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 205470.KQHUMASIS Co., Ltd. | $2880.00 | -2.04% | $65.2B | — |
| 001360.KSSAMSUNG PHARM. Co., Ltd. | $1376.00 | -0.86% | $129.5B | — |
| 002390.KSHANDOK Inc. | $8640.00 | -2.81% | $112.2B | — |
| 002620.KSJeil Pharma Holdings Inc | $7600.00 | -1.04% | $116.7B | — |
| 004080.KSShinhung Co., Ltd | $14040.00 | -0.07% | $130.0B | — |
| 214390.KSKyongbo Pharmaceutical Co., Ltd | $5400.00 | +0.37% | $129.1B | — |
| 235980.KQMedPacto, Inc. | $2865.00 | +4.18% | $98.2B | — |
Source: Financial Modeling Prep · peers by sector/industry